X0708 D/A LIVE 0001491841 Cytogel Pharma, LLC 3 THORNDAL CIRCLE DARIEN CT CONNECTICUT 06820 203-966-9867 CONNECTICUT None None Limited Liability Company true C. Dean Maglaris 84 Beacon Hill Lane New Canaan CT CONNECTICUT 06840 Executive Officer Director The issuer is an LLC; the "director" function is fulfilled by Managers. Jerry P. Leamon 280 Cognewaugh Road Cos Cob CT CONNECTICUT 06807 Director The issuer is an LLC; the "director" function is fulfilled by Managers. Cassandra Klimp 175 Rennell Drive, #248 Southport CT CONNECTICUT 06890 Director The issuer is an LLC; the "director" function is fulfilled by Managers. Frederick W. Telling 2068 Country Club Drive Port Orange FL FLORIDA 32128 Executive Officer Director The issuer is an LLC; the "director" function is fulfilled by Managers. Steven Chrust 70 Washington Street, Apt PHQ Brooklyn NY NEW YORK 11201 Director The issuer is an LLC; the "director" function is fulfilled by Managers. Michael Ullmann 73 Magnolia Lane Princeton NJ NEW JERSEY 08540 Director The issuer is an LLC; the "director" function is fulfilled by Managers. Eric Lang 16 Jeffers Road Plainsboro NJ NEW JERSEY 08536 Director The issuer is an LLC; the "director" function is fulfilled by Managers. Theodore Maione c/o Cytogel Pharma, LLC 333 Broadway, Suite 420 Troy NY NEW YORK 12180 Executive Officer Dr. Maione is the Issuer's Chief Scientific Officer. Pharmaceuticals Decline to Disclose 06b true 0001213900-25-124742 true false true false 50000 FDX Capital LLC 000119302 None None 515 Madison Avenue, 24th Floor New York NY NEW YORK 10022 All States false XMS Capital Partners, LLC 000142871 None None 321 N Clark Street, Suite 2440 Chicago IL ILLINOIS 60654 All States false 16000000 0 16000000 false 0 1120000 true 0 true The placement agent is entitled to a cash sales commission in an amount ranging from 2% to 7% of the aggregate amount of membership units sold depending upon the purchaser. The placement agent also is entitled to warrants. 180000 true false Cytogel Pharma, LLC /s/ C. Dean Maglaris C. Dean Maglaris Chief Executive Officer 2026-03-26